1. Left ventricular systolic dysfunction in 75-year-old men and women. A population-based study
- Author
-
Kenneth Pehrsson, Göran E. Nilsson, Ingemar Lönnberg, Tommy Jonason, Ivar Ringqvist, and Pär Hedberg
- Subjects
Male ,medicine.medical_specialty ,Heart disease ,Systole ,medicine.drug_class ,Coronary Disease ,Sensitivity and Specificity ,Severity of Illness Index ,Asymptomatic ,Diabetes Complications ,Ventricular Dysfunction, Left ,Age Distribution ,Risk Factors ,Surveys and Questionnaires ,Internal medicine ,Prevalence ,Natriuretic peptide ,medicine ,Humans ,cardiovascular diseases ,Sex Distribution ,Aged ,Heart Failure ,Sweden ,Ejection fraction ,business.industry ,Incidence (epidemiology) ,Urban Health ,Stroke Volume ,medicine.disease ,Population based study ,medicine.anatomical_structure ,Echocardiography ,Ventricle ,Population Surveillance ,Heart failure ,Hypertension ,Exercise Test ,cardiovascular system ,Cardiology ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
Reduced performance of the left ventricle to eject blood – left ventricular systolic dysfunction (LVSD) – is a common predecessor of the heart failure syndrome. With or without symptoms, LVSD is associated with a poor prognosis. However, with adequate treatment, the development or progression of symptoms, the need for hospitalisation and mortality can all be reduced. In the present work, the occurrence of LVSD was evaluated by echocardiography in a community-based sample of 75-year-old men and women (n = 433). LVSD was a common condition, with a prevalence rate of 6.8%. In nearly half the participants with LVSD, there was no clinical evidence of heart failure.Community-based screening for asymptomatic LVSD has been proposed as a strategy to reduce the incidence of heart failure. Because of the high costs and low availability, echocardiography is not a suitable screening tool. The plasma concentration of B-type natriuretic peptide (BNP) has been the most advocated screening tool. Another alternative is the standard 12-lead electrocardiogram (ECG). Both the ECG and BNP were effective in excluding LVSD in our 75-year-old community-based sample. However, compared with BNP, the ECG had considerably better specificity. In screening for LVSD, BNP had a diagnostic value in addition to the ECG, but only in individuals with abnormal ECGs.The left ventricular ejection fraction (LVEF) measured by echocardiography is a well-established index for describing left ventricular systolic function. The wall motion index (WMI) and the amplitude of mitral annulus motion (MAM) are suggested as alternative echocardiographic methods. Compared with MAM, the WMI had a more favourable agreement with the LVEF in our 75-year-old participants. Nonetheless, MAM was a strong predictor of mortality. MAM predicted the risk of all-cause and cardiac mortality independently of other risk factors. In addition, when it came to cardiac mortality, the predictive ability of MAM was independent of the LV function measured as the WMI.
- Published
- 2001
- Full Text
- View/download PDF